Skip to main content
. 2014 Jan 7;16(3):364–371. doi: 10.4103/1008-682X.122585

Figure 1.

Figure 1

Overall survival curve for (a) ipilimumab (reproduced from Hodi et al.101), (b) sipuleucel-T (reproduced from Kantoff et al.115) and (c) PSA-TRICOM (reproduced from Kantoff et al.29)